Who
Anna Richo
Director
Company insider
Files Form 4 as: Director, Illumina; Director, Exelon; Director, Adamas Pharmaceuticals; SVP & Cco, Amgen.
In numbers
- Trades disclosed
- 156
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $8.5M
- Companies
- 4
- Companies where not an officer
- 3
- First trade
- 31 Jul 2008
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 21 May 2026filed 22 May 2026 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | $300K2,072 at $144.83 | filing |
| 28 Apr 2026filed 29 Apr 2026 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | —3,720 at $0.00 | filing |
| 28 Apr 2026filed 29 Apr 2026 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | —3,720 at $0.00 | filing |
| 31 Mar 2026filed 1 Apr 2026 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $44K878 at $49.82 | filing |
| 31 Mar 2026filed 1 Apr 2026 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $44K878 at $49.82 | filing |
| 31 Dec 2025filed 2 Jan 2026 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K940 at $43.87 | filing |
| 31 Dec 2025filed 2 Jan 2026 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K717 at $43.59 | filing |
| 31 Dec 2025filed 2 Jan 2026 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K717 at $43.59 | filing |
| 31 Dec 2025filed 2 Jan 2026 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K940 at $43.87 | filing |
| 30 Sep 2025filed 1 Oct 2025 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K694 at $45.01 | filing |
| 30 Sep 2025filed 1 Oct 2025 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K950 at $43.43 | filing |
| 30 Jun 2025filed 2 Jul 2025 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K719 at $43.42 | filing |
| 30 Jun 2025filed 2 Jul 2025 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K954 at $43.25 | filing |
| 21 May 2025filed 23 May 2025 | ILMN IlluminaLife-science tools | SEC FORM 4 Code A | —3,780 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K678 at $46.08 | filing |
| 31 Mar 2025filed 2 Apr 2025 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K933 at $44.19 | filing |
| 31 Dec 2024filed 3 Jan 2025 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K830 at $37.64 | filing |
| 31 Dec 2024filed 3 Jan 2025 | EXC ExelonElectric Utilities & IPPs | SEC FORM 4 Code A | $41K1,119 at $36.87 | filing |
| 30 Sep 2024filed 2 Oct 2024 | EXC Exelonoption or derivative · Electric Utilities & IPPs | SEC FORM 4 Code A | $31K771 at $40.55 | filing |
News
Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?AMGN · insidermonkey.com · 13 Oct 2026Amgen (AMGN) and Johnson & Johnson (JNJ) Catch Jim Cramer's Eye for Different ReasonsAMGN · insidermonkey.com · 8 Oct 20261,272 Amgen Inc. $AMGN Shares Purchased by Venture Visionary Partners LLCAMGN · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Anna Richo; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.